Pharmafile Logo
Pharmafocus logo
Advanced Search

Novo Nordisk

Showing 15 posts of 188 posts found.

Novo Nordisk's Victoza (liraglutide)

Victoza data shows promise for early setting

September 13, 2011
Research and Development, Sales and Marketing Novo Nordisk, Victoza

New data for Novo Nordisk’s Victoza could help the drug’s chances of being used in an earlier setting for type …

News
Novo Nordisk

Novo Nordisk invests €134m in Danish facility

June 24, 2011
Manufacturing and Production Novo Nordisk, biologics, pharma manufacturing news

Novo Nordisk plans to invest almost 1 billion Danish kroner (134 million euros) in a new biologics manufacturing facility at …

News
Novo Nordisk headquarters

New product can overtake Lantus, says Novo leader

May 11, 2011
Sales and Marketing Novo Nordisk, degludec, diabetes, insulin

Novo Nordisk’s new insulin product can eclipse Sanofi’s Lantus within just a few years of its launch, according to Novo’s …

News
Novo Nordisk's type II diabetes drug Victoza (liraglutide)

Novo’s diabetes drug Victoza approved in China

March 16, 2011
Sales and Marketing Glucagon-Like Peptide-1, Novo Nordisk, Victoza, diabetes in China, liraglutide, type 2 diabetes

Novo Nordisk’s injectable diabetes drug Victoza has been given regulatory approval in China. The Chinese State Food and Drug Administration …

News
Diabetes injection

Pharma-NHS diabetes project begins

February 9, 2011
Sales and Marketing AstraZeneca, Lilly UK, MSD, NHS, Nottingham, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, joint working

A joint venture between the NHS, charities and the pharma sector has begun in Nottingham to help treat the city’s …

News
Novo Nordisk's Victoza

Diabetes drugs show promise in Alzheimer’s

January 17, 2011
Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide

Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …

News

GSK’s Dr Anne Phillips moves to Novo Nordisk

January 4, 2011
Research and Development, Sales and Marketing Dr Anne Phillips, Novo Nordisk, apppointment, research and development, sales and marketing

Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …

Appointment

Novo to develop oral insulin

December 22, 2010
Research and Development Emisphere, Novo Nordisk, diabetes, insulin, oral insulin, type I diabetes

Novo Nordisk is to develop an oral formulation of insulin with US biotech company Emisphere Technologies. The New Jersey-based biotech …

News
ABPI

Novo rebuked after diabetes promotion breaches Code

December 16, 2010
Medical Communications ABPI, ABPI Code of Practice, Grunenthal, Napp Pharmaceuticals, Novo Nordisk, PMCPA, diabetes, diabetes drug marketing, lilly

Novo Nordisk been ‘named and shamed’ in health trade journal advertisements this week for breaching the ABPI Code of Practice. …

News

Novo Nordisk invests $73m to boost diabetes drug production

October 8, 2010
Manufacturing and Production Novo Nordisk, diabetes, insulin

Novo Nordisk has announced another major expansion of its manufacturing capacity for diabetes products, setting aside $73 million to expand …

News
Novo Dose diabetes iPhone app

Digital Pharma: Novo launches insulin dosing app

September 17, 2010
Medical Communications, Sales and Marketing Digital Pharma blog, Novo Nordisk, app, diabetes, iphone

Novo Nordisk has launched an iPhone app for US healthcare professionals that enables to them look up dosing guidelines for …

News

Novo expands diabetes research in China

September 16, 2010
Research and Development China, Novo Nordisk, diabetes

Diabetes is at the core of Novo Nordisk’s latest investment in China, where the company plans to more than double …

News
Novo Nordisk's Victoza

Low dose Victoza on track for NICE approval

September 10, 2010
Sales and Marketing NICE, Novo Nordisk, Victoza

Novo Nordisk is on track to receive NICE approval for its type II diabetes drug Victoza, but will still have …

News

Victoza lifts Novo Nordisk

August 9, 2010
Sales and Marketing 2010 financials, Novo Nordisk, Q2

Novo Nordisk has posted a set of healthy results following strong sales from its insulin range and newly launched diabetes …

News

Novo agrees price cut deal with Greece

June 16, 2010
Sales and Marketing Greece, Novo Nordisk, insulin, pricing

Novo Nordisk has agreed to resume supply of its insulins to the Greek market after pulling them last month as …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026